Opposition to Nonprescription Naloxone Access: Measurement and Psychosocial Predictors

References

• Aichholzer, J., & Zandonella, M. (2016). Psychological bases of support for radical right parties. Personality and Individual Differences, 96, 185–190. doi:10.1016/j.paid.2016.02.072
   Web of Science ®Google Scholar
• Bachhuber, M. A., McGinty, E. E., Kennedy-Hendricks, A., Niederdeppe, J., & Barry, C. L. (2015). Messaging to increase public support for naloxone distribution policies in the United States: Results from a randomized survey experiment. PLoS One, 10(7), e0130050. doi:10.1371/journal.pone.0130050
   PubMed Web of Science ®Google Scholar
• Bradburn, N. M., Sudman, S., & Wansink, B. (2004). Asking questions: The definitive guide to questionnaire design–for market research, political polls, and social and health questionnaires: San Francisco, CA: Jossey-Bass.
   Google Scholar
• Correal, A. (2018, April 12). Overdose antidote is supposed to be easy to get. It’s not. The New York Times, Retrieved from https://www.nytimes.com/2018/04/12/nyregion/overdose-antidote-naloxone-investigation-hard-to-buy.html
   Google Scholar
• Cruz, M. F., Patra, J., Fischer, B., Rehm, J., & Kalousek, K. (2007). Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. International Journal of Drug Policy, 18(1), 54–61. doi:10.1016/j.drugpo.2006.12.001
   PubMed Web of Science ®Google Scholar
• Davis, C., & Carr, D. (2017). State legal innovations to encourage naloxone dispensing. Journal of the American Pharmacists Association (2003), 57(2), S180–S184. doi:10.1016/j.japh.2016.11.007
   PubMed Web of Science ®Google Scholar
• Firth, J., Kirzinger, A., & Brodie, M. (2016). Kaiser Health Tracking Poll: April 2016. Retrieved from https://www.kff.org/report-section/kaiser-health-tracking-poll-april-2016-substance-abuse-and-mental-health/
   Google Scholar
• Gottlieb, S. (2019). Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths [Press release]. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm
   Google Scholar
• Graham, J., Haidt, J., Koleva, S., Motyl, M., Iyer, R., Wojcik, S. P., & Ditto, P. H. (2013). Moral foundations theory: The pragmatic validity of moral pluralism. In P. Devine & A. Plant (Eds.), Advances in experimental social psychology (Vol. 47, pp. 55–130). Academic Press.
   Google Scholar
• Green, T. C., Bowman, S. E., Zaller, N. D., Ray, M., Case, P., & Heimer, R. (2013). Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Substance Use & Misuse, 48(7), 558–567. doi:10.3109/10826084.2013.787099
   PubMed Web of Science ®Google Scholar
• Green, T. C., Zaller, N., Palacios, W. R., Bowman, S. E., Ray, M., Heimer, R., & Case, P. (2013). Law enforcement attitudes toward overdose prevention and response. Drug and Alcohol Dependence, 133(2), 677–684. doi:10.1016/j.drugalcdep.2013.08.018
   PubMed Web of Science ®Google Scholar
• Harper, J. (2018). May 7, 2018. Reversing an overdose isn't complicated, but getting the antidote can be. NPR. Retrieved from https://www.npr.org/sections/health-shots/2018/05/07/607760827/reversing-an-overdose-isnt-complicated-but-getting-the-antidote-can-be
   Google Scholar
• Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward #naloxone on Twitter. Substance Abuse, 37(1), 35–41. doi:10.1080/08897077.2015.1129390
   PubMed Web of Science ®Google Scholar
• Ho, A. K., Sidanius, J., Kteily, N., Sheehy-Skeffington, J., Pratto, F., Henkel, K. E., … Stewart, A. L. (2015). The nature of social dominance orientation: Theorizing and measuring preferences for intergroup inequality using the new SDO(7) scale. Journal of Personality and Social Psychology, 109(6), 1003–1028. doi:10.1037/pspi0000033
   PubMed Web of Science ®Google Scholar
• Information about Naloxone (2019). January 24, 2019. Retrieved from https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm472923.htm
   Google Scholar
• Jones, C. M. (2013). Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug & Alcohol Dependence, 132(1), 95–100. doi:10.1016/j.drugalcdep.2013.01.007
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health–oriented policies. Psychiatric Services, 68(5), 462–469. doi:10.1176/appi.ps.201600056
   PubMed Web of Science ®Google Scholar
• Kulesza, M., Teachman, B. A., Werntz, A. J., Gasser, M. L., & Lindgren, K. P. (2015). Correlates of public support toward federal funding for harm reduction strategies. Substance Abuse Treatment, Prevention, and Policy, 10(1), 25. doi:10.1186/s13011-015-0022-5
   PubMedGoogle Scholar
• Levin, S., Federico, C. M., Sidanius, J., & Rabinowitz, J. L. (2002). Social dominance orientation and intergroup bias: The legitimation of favoritism for high-status groups. Personality and Social Psychology Bulletin, 28(2), 144–157. doi:10.1177/0146167202282002
   Web of Science ®Google Scholar
• Lucas, T., Zhdanova, L., & Alexander, S. (2011). Procedural and distributive justice beliefs for self and others. Journal of Individual Differences, 32(1), 14–25. doi:10.1027/1614-0001/a000032
   Web of Science ®Google Scholar
• Mahoney, K. (2016, August 10). FDA supports greater access to naloxone to help reduce opioid overdose deaths. Retrieved from https://blogs.fda.gov/fdavoice/index.php/2016/08/fda-supports-greater-access-to-naloxone-to-help-reduce-opioid-overdose-deaths/
   Google Scholar
• Mather, D. M., Jones, S. W., & Moats, S. (2017). Improving upon Bogardus: Creating a more sensitive and dynamic social distance scale. Survey Practice, 10(4), 1. doi:10.29115/SP-2017-0026
   Google Scholar
• Mueller, S. R., Koester, S., Glanz, J. M., Gardner, E. M., & Binswanger, I. A. (2017). Attitudes toward naloxone prescribing in clinical settings: A qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Journal of General Internal Medicine, 32(3), 277–283. doi:10.1007/s11606-016-3895-8
   PubMed Web of Science ®Google Scholar
• Palamar, J. J., Kiang, M. V., & Halkitis, P. N. (2011). Development and psychometric evaluation of scales that assess stigma associated with illicit drug users. Substance Use & Misuse, 46(12), 1457–1467. doi:10.3109/10826084.2011.596606
   PubMed Web of Science ®Google Scholar
• Rasinski, K. A., Timberlake, J. M., & Lock, E. D. (2000). Public support for increased spending on the drug problem in America is not a simple matter. International Journal of Public Opinion Research, 12(4), 431–440. doi:10.1093/ijpor/12.4.431
   Web of Science ®Google Scholar
• Rudski, J. (2016). Public perspectives on expanding naloxone access to reverse opioid overdoses. Substance Use & Misuse, 51(13), 1771–1780. doi:10.1080/10826084.2016.1197267
   PubMed Web of Science ®Google Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths — United States, 2013–2017. Retrieved from
   Google Scholar
• Thornton, J. D., Lyvers, E., Scott, V. G., & Dwibedi, N. (2017). Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. Journal of the American Pharmacists Association, 57(2), S12–S18. doi:10.1016/j.japh.2016.12.070
   PubMed Web of Science ®Google Scholar
• Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J., Centers for Disease Control & Prevention. (2015). Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(23), 631–635.
   PubMed Web of Science ®Google Scholar
• Wilson, J. D., Spicyn, N., Matson, P., Alvanzo, A., & Feldman, L. (2016). Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings. Substance Abuse, 37(3), 480–487. doi:10.1080/08897077.2016.1142921
   PubMed Web of Science ®Google Scholar
• Wright, E., Reed, N., Carnes, N., & Kooreman, H. E. (2016). Concern about the expanding prescription drug epidemic: A survey of licensed prescribers and dispensers. Pain Physician, 19(1), E197–E208.
   PubMed Web of Science ®Google Scholar
• Xu, J., Davis, C. S., Cruz, M., & Lurie, P. (2018). State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. Drug and Alcohol Dependence, 189, 37–41. doi:10.1016/j.drugalcdep.2018.04.020
   PubMed Web of Science ®Google Scholar